MASSAIA, Massimo Giovanni Stefano
MASSAIA, Massimo Giovanni Stefano
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
A PHASE II MULTI-CENTER TRIAL OF PENTOSTATIN PLUS CYCLOPHOSPHAMIDE WITH OFATUMUMAB (PCO) IN OLDER PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS
2014-01-01 Montillo, M; Rossi, D; Motta, M; Quaresmini, G; Rossi, M; Coscia, M; Anastasia, A; Rossini, F; Cortellezzi, A; Nador, G; Scarfo, L; Cairoli, R; Frustaci, Am; Dal Ceggio, D; Picardi, P; De Paoli, L; Orlandi, E; Rambaldi, A; Morra, E; Massaia, M; Tedeschi, A
A PROSPECTIVE PHASE II STUDY ON TANDEM AUTOGRAFTING-ONMYELOABLATIVE ALLOGRAFTING FOR NEWLY DIAGNOSED MULTIPLE MYELOMA: FINAL RESULTS OF A MULTICENTER GITMO (GRUPPO ITALIANO TRAPIANTO MIDOLLO OSSEO) PROTOCOL
2007-01-01 Sorasio R; Patriarca F; Giaccone L; Mattei D; Allione B; Carnevale-Schianca F; Rambaldi A; Casini M; Montefusco V; Parma M; Bavaro P; Onida F; Busca A; Castagna L; Iori AP; Rotta M; Fiore F; Benedetti E; Mordini N; Massaia M; Palumbo A; Aglietta M; Lewis A; Foà R; Di Bartolomeo P; Pogliani E; Lambertenghi-Deliliers G; Falda M; Petrini M; Corradini P; Fanin R; Ricardi U; Ciccone G; Baldi I; Bruno B; Boccadoro M
Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells
2011-01-01 M Coscia; M Rigoni; C Riganti; I Campia; C Vitale; V Griggio; S Peola; B Castella; F Pantaleoni; P Sciancalepore; D Drandi; P Omedè; M Ladetto; A Bosia; M Boccadoro; M Massaia
An Update of a Comparison of Nonmyeloablative Allografting with Autografting for Newly Diagnosed Myeloma.
2007-01-01 B. Bruno; R. Sorasio; F. Patriarca; N. Mordini; B. Allione; F. Carnevale-Schianca; L. Giaccone; M. Rotta; P. Omedè; I. Baldi; S. Bringhen; M. Massaia; M. Aglietta; A. Levis; D. Mattei; R. Fanin; A. Palumbo; R. Storb; G. Ciccone; and Mario Boccadoro
AUTOGRAFTING FOLLOWED BY LOW DOSE TBI BASED NON MYELOABLATIVE ALLOGRAFTING IN NEWLY DIAGNOSED MULTIPLE MYELOMA: THE ITALIAN EXPERIENCE
2004-01-01 Bruno B; Patriarca F; Rotta M; Maloney D; Mordini N; Casini M; Rambaldi A; Carnevale-Schianca F; Allione B; Soligo D; Bavaro P; Giaccone L; Aitoro G; Corradini P; Busca A; Fanin R; Gallamini A; Coser P; Levis A; Aglietta M; Pogliani E; Falda M; Bianchi A; Massaia M; Palumbo A; Sandmaier B; Storb R; Boccadoro M
Autografting followed by low dose TBI based non myeloablative allografting in newly diagnosed multiple myeloma: The Italian experience.
2003-01-01 Bruno B; Patriarca F; Rotta M; Maloney D; Mordini N; Casini M; Rambaldi A; Carnevale-Schianca F; Allione B; Soligo D; Bavaro P; Giaccone L; Aitoro G; Corradini P; Busca A; Fanin R; Gallamini A; Coser P; Levis A; Aglietta M; Pogliani E; Falda M; Bianchi A; Massaia M; Palumbo A; Sandmaier B; Storb R; Boccadoro M
AUTOGRAFTING FOLLOWED BY NON MYELOABLATIVE TBI-BASED ALLOGRATING FOR TREATMENT OF MULTIPLE MYELOMA: A MULTI-CENTER TRIAL
2002-01-01 Bruno B; Patriarca F; Maloney D; Mordini N; Casini M; Rambaldi A; Carnevale F; Allione B; Soligo D; Bavaro P; Aitoro G; Corradini P; Fanin R; Gallamini A; Coser P; Levis A; Aglietta M; Massaia M; Palumbo A; Sandmaier B; Storb R; Boccadoro M
Bendamustine and alemtuzumab (BEN CAM) combination in relapsed and refractory chronic lymphocytic leukaemia (CLL): interim report of the italian trial
2011-01-01 A Tedeschi; M Coscia; D Rossi; F Ricci; G D'Arena; E Orlandi; V Belsito Petrizzi; L Scarfò; C Vitale; E Vismara; G Gaidano; E Morra; M Massaia; M Montillo
BENDAMUSTINE AND ALEMTUZUMAB (BEN CAM) COMBINATION IN RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): PHASE I SAFETY PROFILE RESULTS OF THE ITALIAN TRIAL
2010-01-01 A Tedeschi ;M Coscia ;D Rossi ;E Vismara ;F Ricci ;C Vitale ;E Morra ;G Gaidano ;M Massaia ;M Montillo
BENDAMUSTINE AND ALEMTUZUMAB (BEN CAM) COMBINATION IN RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): PRELIMINARY REPORT OF THE ITALIAN TRIAL
2011-01-01 Tedeschi, A; Coscia, M; Rossi, D; Ricci, F; D'Arena, G; Orlandi, E; Petrizzi, Vb; Scarfo, L; Vitale, C; Vismara, E; Gaidano, G; Morra, E; Massaia, M; Montillo, M
Bendamustine and Alemtuzumab combination in relapsed and refractory chronic lymphocytic leukemia: interim report of the italian trial
2011-01-01 A Tedeschi; M Coscia; D Rossi; F Ricci; G D'Arena; E Orlandi; V Belsito Petrizzi; L Scarfò; C Vitale; E Vismara; G Gaidano; E Morra; M Massaia; M Montillo
CD157 reduces acutemyeloid leukemia cell sensitivity tocytarabine through upregulation of MCL-1 anti-apoptotic protein
2019-01-01 Yuliya Yakymiv, Stefania Augeri, Giulia Fissolo, Cristiano Bracci, Silvia Peola, Stefano D’Ardia, Sembra Aydin, Massimo Massaia, Erika Ortolan, Ada Funaro.
CD157 REGULATES THE SENSITIVITY OF ACUTE MYELOID LEUKEMIA CELLS TO CHEMOTHERAPY BY MODULATING THE APOPTOTIC RESPONSE
2019-01-01 Yuliya Yakymiv, Stefania Augeri, Giulia Fissolo, Cristiano Bracci, Silvia Peola, Stefano D’Ardia, Semra Aydin, Massimo Massaia, Erika Ortolan, Ada Funaro.
Chlorambucil PLUS Rituximab As FRONT-LINE Therapy for Elderly and/or Unfit CLL Patients. LONG-TERM Follow-up and Correlation with Biologic-Based Risk Stratification
2016-01-01 Laurenti, L; Innocenti, I; Autore, F; Pasquale, R; Vannata, B; Ciolli, S; Mauro, Fr; Mannina, D; Del Poeta, G; D'Arena, G; Massaia, M; Coscia, M; Molica, S; Pozzato, G; Efremov, Dg; Marasca, R; Galieni, P; Cuneo, A; Orlando, S; Piciocchi, A; Boncompagni, R; Vincelli, Di; Liberati, Am; Russo, F; Foa, R
Dendritic Cells Can Be Primed to Concurrently Activate Both Unconventional Gamma/delta and Conventional alpha/beta T Cells
2006-01-01 Francesca Fiore; Barbara Castella; Barbara Nuschak; Raffaello Bertieri; Sara Mariani; Serena Zappia; Marta Coscia; Mario Boccadoro; Massimo Massaia
Differential Effects of Microenvironmental Elements On Tumor Cells Survival in Chronic Lymphocytic Leukemia Patient Subsets with Good or Poor Prognosis
2009-01-01 Marta Coscia; Francesca Pantaleoni; Chiara Riganti; Micol Rigoni; Candida Vitale; Silvia Peola; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia
Distribution of γδ T cells in patients with hematological malignancies
2006-01-01 Mariani, S; Pantaleoni, F.; Peola, S.; Hwang, S.Y.; Castella, B.; Matta, G.; Foglietta, M.; Fiore, F.; Coscia, M.A.; Boccadoro, M.; Massaia, M.
Double Autologous Transplant Versus Tandem Autologus - Non Myeloablative Allogeneic Transplant for Newly Diagnosed Multiple Myeloma.
2005-01-01 B. Bruno; M. Rotta; F. Patriarca; N. Mordini; B. Allione; F. CarnevaleSchianca; L. Giaccone; P. Omedè; R. Sorasio; M. Giarin; P. Falco; M.T. Ambrosini; S. Bringhen; D. Mattei; M. Massaia; A. Palumbo; M. Aglietta; A. Levis; A. Gallamini; R. Fanin; R. Storb; G. Ciccone; and M. Boccadoro
Effective anti-tumor immunomodulatory properties of zoledronic acid
2007-01-01 Coscia M; Quaglino E; Pantaleoni F; Curcio C; Rigoni M; Forni G; Massaia M
Effective anti-tumor immunomodulatory properties of zoledronic acid in Balb/c mice transgenic for the her-2/Neu oncogene
2006-01-01 Coscia M; Quaglino E; Pantaleoni F; Curcio C; Boccadoro M; Forni G; Massaia M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A PHASE II MULTI-CENTER TRIAL OF PENTOSTATIN PLUS CYCLOPHOSPHAMIDE WITH OFATUMUMAB (PCO) IN OLDER PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS | 2014 | Montillo, M; Rossi, D; Motta, M; Quaresmini, G; Rossi, M; Coscia, M; Anastasia, A; Rossini, F; Cortellezzi, A; Nador, G; Scarfo, L; Cairoli, R; Frustaci, Am; Dal Ceggio, D; Picardi, P; De Paoli, L; Orlandi, E; Rambaldi, A; Morra, E; Massaia, M; Tedeschi, A | |
| A PROSPECTIVE PHASE II STUDY ON TANDEM AUTOGRAFTING-ONMYELOABLATIVE ALLOGRAFTING FOR NEWLY DIAGNOSED MULTIPLE MYELOMA: FINAL RESULTS OF A MULTICENTER GITMO (GRUPPO ITALIANO TRAPIANTO MIDOLLO OSSEO) PROTOCOL | 2007 | Sorasio R; Patriarca F; Giaccone L; Mattei D; Allione B; Carnevale-Schianca F; Rambaldi A; Casini M; Montefusco V; Parma M; Bavaro P; Onida F; Busca A; Castagna L; Iori AP; Rotta M; Fiore F; Benedetti E; Mordini N; Massaia M; Palumbo A; Aglietta M; Lewis A; Foà R; Di Bartolomeo P; Pogliani E; Lambertenghi-Deliliers G; Falda M; Petrini M; Corradini P; Fanin R; Ricardi U; Ciccone G; Baldi I; Bruno B; Boccadoro M | |
| Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells | 2011 | M Coscia; M Rigoni; C Riganti; I Campia; C Vitale; V Griggio; S Peola; B Castella; F Pantaleoni; P Sciancalepore; D Drandi; P Omedè; M Ladetto; A Bosia; M Boccadoro; M Massaia | |
| An Update of a Comparison of Nonmyeloablative Allografting with Autografting for Newly Diagnosed Myeloma. | 2007 | B. Bruno; R. Sorasio; F. Patriarca; N. Mordini; B. Allione; F. Carnevale-Schianca; L. Giaccone; M. Rotta; P. Omedè; I. Baldi; S. Bringhen; M. Massaia; M. Aglietta; A. Levis; D. Mattei; R. Fanin; A. Palumbo; R. Storb; G. Ciccone; and Mario Boccadoro | |
| AUTOGRAFTING FOLLOWED BY LOW DOSE TBI BASED NON MYELOABLATIVE ALLOGRAFTING IN NEWLY DIAGNOSED MULTIPLE MYELOMA: THE ITALIAN EXPERIENCE | 2004 | Bruno B; Patriarca F; Rotta M; Maloney D; Mordini N; Casini M; Rambaldi A; Carnevale-Schianca F; Allione B; Soligo D; Bavaro P; Giaccone L; Aitoro G; Corradini P; Busca A; Fanin R; Gallamini A; Coser P; Levis A; Aglietta M; Pogliani E; Falda M; Bianchi A; Massaia M; Palumbo A; Sandmaier B; Storb R; Boccadoro M | |
| Autografting followed by low dose TBI based non myeloablative allografting in newly diagnosed multiple myeloma: The Italian experience. | 2003 | Bruno B; Patriarca F; Rotta M; Maloney D; Mordini N; Casini M; Rambaldi A; Carnevale-Schianca F; Allione B; Soligo D; Bavaro P; Giaccone L; Aitoro G; Corradini P; Busca A; Fanin R; Gallamini A; Coser P; Levis A; Aglietta M; Pogliani E; Falda M; Bianchi A; Massaia M; Palumbo A; Sandmaier B; Storb R; Boccadoro M | |
| AUTOGRAFTING FOLLOWED BY NON MYELOABLATIVE TBI-BASED ALLOGRATING FOR TREATMENT OF MULTIPLE MYELOMA: A MULTI-CENTER TRIAL | 2002 | Bruno B; Patriarca F; Maloney D; Mordini N; Casini M; Rambaldi A; Carnevale F; Allione B; Soligo D; Bavaro P; Aitoro G; Corradini P; Fanin R; Gallamini A; Coser P; Levis A; Aglietta M; Massaia M; Palumbo A; Sandmaier B; Storb R; Boccadoro M | |
| Bendamustine and alemtuzumab (BEN CAM) combination in relapsed and refractory chronic lymphocytic leukaemia (CLL): interim report of the italian trial | 2011 | A Tedeschi; M Coscia; D Rossi; F Ricci; G D'Arena; E Orlandi; V Belsito Petrizzi; L Scarfò; C Vitale; E Vismara; G Gaidano; E Morra; M Massaia; M Montillo | |
| BENDAMUSTINE AND ALEMTUZUMAB (BEN CAM) COMBINATION IN RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): PHASE I SAFETY PROFILE RESULTS OF THE ITALIAN TRIAL | 2010 | A Tedeschi ;M Coscia ;D Rossi ;E Vismara ;F Ricci ;C Vitale ;E Morra ;G Gaidano ;M Massaia ;M Montillo | |
| BENDAMUSTINE AND ALEMTUZUMAB (BEN CAM) COMBINATION IN RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): PRELIMINARY REPORT OF THE ITALIAN TRIAL | 2011 | Tedeschi, A; Coscia, M; Rossi, D; Ricci, F; D'Arena, G; Orlandi, E; Petrizzi, Vb; Scarfo, L; Vitale, C; Vismara, E; Gaidano, G; Morra, E; Massaia, M; Montillo, M | |
| Bendamustine and Alemtuzumab combination in relapsed and refractory chronic lymphocytic leukemia: interim report of the italian trial | 2011 | A Tedeschi; M Coscia; D Rossi; F Ricci; G D'Arena; E Orlandi; V Belsito Petrizzi; L Scarfò; C Vitale; E Vismara; G Gaidano; E Morra; M Massaia; M Montillo | |
| CD157 reduces acutemyeloid leukemia cell sensitivity tocytarabine through upregulation of MCL-1 anti-apoptotic protein | 2019 | Yuliya Yakymiv, Stefania Augeri, Giulia Fissolo, Cristiano Bracci, Silvia Peola, Stefano D’Ardia, Sembra Aydin, Massimo Massaia, Erika Ortolan, Ada Funaro. | |
| CD157 REGULATES THE SENSITIVITY OF ACUTE MYELOID LEUKEMIA CELLS TO CHEMOTHERAPY BY MODULATING THE APOPTOTIC RESPONSE | 2019 | Yuliya Yakymiv, Stefania Augeri, Giulia Fissolo, Cristiano Bracci, Silvia Peola, Stefano D’Ardia, Semra Aydin, Massimo Massaia, Erika Ortolan, Ada Funaro. | |
| Chlorambucil PLUS Rituximab As FRONT-LINE Therapy for Elderly and/or Unfit CLL Patients. LONG-TERM Follow-up and Correlation with Biologic-Based Risk Stratification | 2016 | Laurenti, L; Innocenti, I; Autore, F; Pasquale, R; Vannata, B; Ciolli, S; Mauro, Fr; Mannina, D; Del Poeta, G; D'Arena, G; Massaia, M; Coscia, M; Molica, S; Pozzato, G; Efremov, Dg; Marasca, R; Galieni, P; Cuneo, A; Orlando, S; Piciocchi, A; Boncompagni, R; Vincelli, Di; Liberati, Am; Russo, F; Foa, R | |
| Dendritic Cells Can Be Primed to Concurrently Activate Both Unconventional Gamma/delta and Conventional alpha/beta T Cells | 2006 | Francesca Fiore; Barbara Castella; Barbara Nuschak; Raffaello Bertieri; Sara Mariani; Serena Zappia; Marta Coscia; Mario Boccadoro; Massimo Massaia | |
| Differential Effects of Microenvironmental Elements On Tumor Cells Survival in Chronic Lymphocytic Leukemia Patient Subsets with Good or Poor Prognosis | 2009 | Marta Coscia; Francesca Pantaleoni; Chiara Riganti; Micol Rigoni; Candida Vitale; Silvia Peola; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia | |
| Distribution of γδ T cells in patients with hematological malignancies | 2006 | Mariani, S; Pantaleoni, F.; Peola, S.; Hwang, S.Y.; Castella, B.; Matta, G.; Foglietta, M.; Fiore, F.; Coscia, M.A.; Boccadoro, M.; Massaia, M. | |
| Double Autologous Transplant Versus Tandem Autologus - Non Myeloablative Allogeneic Transplant for Newly Diagnosed Multiple Myeloma. | 2005 | B. Bruno; M. Rotta; F. Patriarca; N. Mordini; B. Allione; F. CarnevaleSchianca; L. Giaccone; P. Omedè; R. Sorasio; M. Giarin; P. Falco; M.T. Ambrosini; S. Bringhen; D. Mattei; M. Massaia; A. Palumbo; M. Aglietta; A. Levis; A. Gallamini; R. Fanin; R. Storb; G. Ciccone; and M. Boccadoro | |
| Effective anti-tumor immunomodulatory properties of zoledronic acid | 2007 | Coscia M; Quaglino E; Pantaleoni F; Curcio C; Rigoni M; Forni G; Massaia M | |
| Effective anti-tumor immunomodulatory properties of zoledronic acid in Balb/c mice transgenic for the her-2/Neu oncogene | 2006 | Coscia M; Quaglino E; Pantaleoni F; Curcio C; Boccadoro M; Forni G; Massaia M |